Buying Know-How to Scale Vaccine Manufacturing
6 min readMar 20, 2021
The development of a number of COVID 19 vaccines has been an impressive achievement, one that can be attributed to a genuine sense that this was an emergency, and the fact that governments spent billions of dollars to subsidize or completely pay for research and development, and de-risking the scale up of products through massive advanced purchase contracts. What has been less impressive has been the effort to scale the manufacturing efforts to meet demand. One tool that has not been used, and should be mobilized, right now, is to spend money to make the know-how a global…